TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 251.23% | 436.58% | 181.16% | 2,288.73% | 580.13% |
| Total Depreciation and Amortization | 43.16% | 31.01% | 39.10% | 64.77% | 92.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -189.75% | -211.48% | 34.83% | -25.58% | -23.17% |
| Change in Net Operating Assets | 183.88% | 140.84% | 139.98% | 56.55% | -0.42% |
| Cash from Operations | 345.96% | 295.14% | 375.35% | 386.00% | 732.95% |
| Capital Expenditure | 38.84% | 54.33% | 63.70% | 54.97% | 42.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | 102.96% | 102.96% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 38.60% | 54.18% | 63.60% | 62.45% | 52.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.35% | -25.70% | -33.30% | 17.77% | 258.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.56% | -26.30% | -33.91% | 17.77% | -94.32% |
| Foreign Exchange rate Adjustments | 11,800.00% | 336.94% | 10.38% | 821.67% | 90.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 523.05% | 360.85% | 240.27% | 117.22% | -125.92% |